MassBio reveals line-up for its biotech accelerator
The selected companies, the inaugural cohort for MassBioDrive, get to participate in an eight-week program focused on growing businesses and advancing breakthrough science.
Archives for March 15, 2022
Novartis inks contract manufacturing deal with Carisma
Novartis continues down the third-party manufacturing route, as it secures an agreement with Carisma Therapeutics, a firm developing a cell therapy platform focused on engineered macrophage-based therapeutics.
Tevogen Bio receives new investment for precision T cell platform
Clinical stage biotech Tevogen Bio has announced a new strategic investment by HMP Partners, a life sciences investment firm.
Sanofi announces €300m collaboration with Blackstone Life Sciences for multiple myeloma treatment
Sanofi and Blackstone today announced a strategic, risk-sharing collaboration under which funds managed by Blackstone Life Sciences will contribute up to €300m ($329m) to accelerate development for subcutaneous formulation and delivery of anti-CD38...